Scaling the Agentforce Life Sciences Ecosystem to Drive the Future of Pharma and MedTech
Salesforce just unlocked agents for pharma. Here's why that matters for the $2T life sciences market.
Why it matters
Salesforce is shipping Agentforce into life sciences workflows through expanded partner ecosystem. This is a vertical-specific agent product play—not a model release, but infrastructure for enterprises to deploy AI agents at scale in regulated industries.
The key facts
8 to knowSalesforce expanding Agentforce partner ecosystem for life sciences
Focus on Systems Integrators (SIs) and specialized content partnerships
Targeting pharma and medtech 'Agentic Enterprise' transformation
Published April 30, 2026
Focus on Systems Integrators and specialized content partnerships
Target: helping pharma/medtech transition to 'Agentic Enterprises'
Published April 30, 2026 — recent ecosystem announcement
No specific revenue, customer count, or deployment metrics disclosed in excerpt
Go to the source
Salesforce Blogsalesforce.com
Publisher excerpt: Salesforce is expanding its partner ecosystem for life sciences, aimed to help accelerate the industry’s imperative to transform into Agentic Enterprises. This growth includes deeper collaborations with leading Systems Integrators (SIs), specialized Content…